Development of a high dimensional imaging mass cytometry panel to investigate spatial organization of tissue microenvironment in formalin-fixed archival clinical tissues.

Autor: Tornaas S; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway., Kleftogiannis D; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway.; Computional Biology Unit, Department of Informatics, University of Bergen, Norway., Fromreide S; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway., Smeland HY; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Aarstad HJ; Department for Ear-Nose-and-Throat, Head and Neck Clinic, Haukeland University Hospital, Bergen, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Akslen LA; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Costea DE; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Dongre HN; Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway.

Publikováno v: Heliyon [Heliyon] 2024 May 14; Vol. 10 (10), pp. e31191. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer.

Autor: Yndestad S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Engebrethsen C; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Herencia-Ropero A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Nikolaienko O; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway.; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Lillestøl RK; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Minsaas L; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Leirvaag B; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Iversen GT; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Blix ES; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Lundgren S; Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aase HS; Department of Radiology, Haukeland University Hospital, Bergen, Norway., Aas T; Department of Surgery, Haukeland University Hospital, Bergen, Norway., Gudlaugsson EG; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Llop-Guevara A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Serra V; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Lønning PE; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Knappskog S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Eikesdal HP; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Deceased.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300338.

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program-A Prospective Observational Study from Western Norway.

Autor: Øvestad IT; Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway., Dalen I; Department of Research, Stavanger University Hospital, 4011 Stavanger, Norway., Andersland MS; Department of Pathology, Haukeland University Hospital, 5053 Bergen, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, 5053 Bergen, Norway.; Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway., Moltu P; Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway., Berland JM; Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway., Janssen EAM; Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Technology, University of Stavanger, 4021 Stavanger, Norway., Haugland HK; Department of Pathology, Haukeland University Hospital, 5053 Bergen, Norway.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 12; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 12.

Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma Patients.

Autor: Haave H; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020 Bergen, Norway., Ljokjel B; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020 Bergen, Norway., Lybak H; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020 Bergen, Norway., Moe SE; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020 Bergen, Norway., Berge JE; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020 Bergen, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, 5020 Bergen, Norway.; Department of Clinical Medicine, Faculty of Medicine, University of Bergen, 5020 Bergen, Norway., Helgeland L; Department of Pathology, Haukeland University Hospital, 5020 Bergen, Norway.; Department of Clinical Medicine, Faculty of Medicine, University of Bergen, 5020 Bergen, Norway., Aarstad HJ; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020 Bergen, Norway.; Department of Clinical Medicine, Faculty of Medicine, University of Bergen, 5020 Bergen, Norway.

Publikováno v: Biomedicines [Biomedicines] 2022 Oct 05; Vol. 10 (10). Date of Electronic Publication: 2022 Oct 05.

Granulocyte macrophage-colony stimulating factor and keratinocyte growth factor control of early stages of differentiation of oral epithelium.

Autor: Das R; Center for Cancer Biomarkers CCBIO and Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway., Virlan MJR; Center for Cancer Biomarkers CCBIO and Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Oral Rehabilitation and Department of Biochemistry, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania., Xenaki V; Center for Cancer Biomarkers CCBIO and Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway., Kulasekara KK; Department of Pharmacy & Applied Science, College of Science, Health & Engineering, La Trobe University, Bendigo, Victoria, Australia., Lukandu O; Maxillofacial Surgery and Pathology, School of Dentistry, Moi University, Eldoret, Kenya., Neppelberg E; Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Oral and Maxillofacial Surgery, Head and Neck Clinic, Haukeland University Hospital, Bergen, Norway., Vintermyr OK; Center for Cancer Biomarkers CCBIO and Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Johannessen AC; Center for Cancer Biomarkers CCBIO and Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Calenic B; Department of Oral Rehabilitation and Department of Biochemistry, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania., Costea DE; Center for Cancer Biomarkers CCBIO and Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway.

Publikováno v: European journal of oral sciences [Eur J Oral Sci] 2022 Jun; Vol. 130 (3), pp. e12867. Date of Electronic Publication: 2022 Apr 22.